DAVID M. STOUT

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

JABIL INC

Filing Date Source Excerpt
2017-12-12 David M. Stout Chair of Compensation Committee Nominating and Corporate Governance Committee Member Director Compensation in Fiscal Year 2017 David M. Stout $90,000 Fees Earned or Paid in Cash $210,528 Stock Awards Total $300,528
2018-12-10 David M. Stout Director since 2009 Chair of Nominating & Corporate Governance Committee Serves on Compensation and Audit Committees Compensation Table shows total $301,947.
2019-12-13 David M. Stout Director since 2009 Independent Chair of Compensation Committee 2019 Compensation: $302,808
2020-12-09 David M. Stout Director since 2009 Independent Age: 66 Chair of Compensation Committee 2020 Total Compensation: $312,431
2021-12-10 David M. Stout Director since 2009 Age: 67 Mr. Stout's extensive business experience in the pharmaceutical industry and his service on boards of other publicly traded companies qualify him for re-election to the Board. Board Committees: Audit Committee, Compensation Committee, Nominating & Corporate Governance Committee 2021 Director Compensation: $310,428
2022-12-09 David M. Stout Retired President, Pharmaceuticals, GlaxoSmithKline Age: 68 Director Since: 2009 Committee Memberships: N&CGC, CSC Compensation: Fees Earned or Paid in Cash $90,000, Stock Awards $212,942, All Other Compensation $1,856, Total $304,798
2023-12-12 David M. Stout, Age: 69, Retired President, Pharmaceuticals, GlaxoSmithKline, Director Since: 2009, Committees: Nominating and Corporate Governance Committee, Cybersecurity Committee, Compensation: $321,044

Data sourced from SEC filings. Last updated: 2026-02-03